Key Practical Learning Points of the Summit:
We are pleased to invite you to the 3rd Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled for May 17-18, 2018 in Barcelona, Spain.
This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development.
The summit will shed light on:
DISCOVERY, DEVELOPMENT & BIOANALYTICAL STRATEGIES TOWARDS NEXT GENERATION ADC:
SUCCESSFUL TRANSLATION INTO CLINIC & CLINICAL PROGRESS:
ESTABLISHING ROBUST MANUFACTURING SUPPLY CHAINS
It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Barcelona in May!
Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.
Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.
6 interactive streams:
View the Agenda here: http://bit.ly/2oJlVB7
Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
With this conference on Medical Biotechnology, VIB will bring together experts in the field to discuss the new developments and future challenges in this field. Four plenary sessions will cover biopharmaceutical technology, targeted delivery, diagnostics & biomarkers and vaccines.
In addition to the scientific sessions there will be ample opportunities to network during the breaks, posters sessions, reception and conference dinner.
The 6th Antibody Industrial Symposium 2018 (AIS2018) congress, organized by the LabEx MAbImprove and MabDesign, offers an ideal conference for scientists, industries, physicians and policy makers to exchange about therapeutic antibodies.
The scientific Committee has set-up an exciting program focusing on the following theme: “Targets for mAbs: Innovative Approaches for their Discovery & Validation”.
The 2 days program includes keynote lectures, pitch talks of new creative projects, industrial talks from pharmaceutical companies and a poster session. Furthermore, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
The topics covered during this meeting are:
-Validated Targets: lessons learned from success & failure in clinical
-Discovery Approaches: Accessing clinical material, Target Identification platforms, OMICS-based analysis
-New Approaches/Technologies for Discovery & Validation of New Targets for mAbs
-Pre-Clinical Validation: Methods, Models & Companion tests
-Emerging Targets: Immunocheckpoints & MicroenvironmentVisit the AIS2018 website to know more and register !:
This 4-day conference will focus attention on key advances in the fields of antibodies, complement and their receptors. 21 invited speakers, 19 oral presentations selected from submitted abstracts, and 2 poster sessions will enable productive exchanges and publicity around your projects and achievements. Attendance is capped at 150. The conference will present recent advances in these exciting fields, in an informal setting designed to maximize interaction. The 4* venue possesses outside pools overseeing the Mediterranean Sea, with direct access to the beach (daily free time slots). >20 travel grants available for students/post-docs.
Topics and Speakers:
2 Keynote Sessions: Paul Parren (U. of Leiden, NL) & George Georgiou (UT Austin, USA)
Novel IgG & complement functions
Structure function relations
Regulation of function & glycosylation
Ab and complement receptors
2 poster sessions with prizes